Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics T.ATE

Alternate Symbol(s):  ATBPF

Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The company's pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs. Antibe's lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids for post-operative pain. Antibe's second pipeline drug, ATB-352, is being developed for a specialized acute pain indication. The company's anticipated next target is inflammatory bowel disease, a condition long in need of safer, more effective therapies.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Mugsy is really shorting

he just pumps to lure in investors .Mugsy is a clown.  rate and reply


9 years later how is the progress   rate and reply


Ten Years later .....still dreams and pies in the sky and no food on the table   rate and reply


Interesting ... if we look back at the 2013 preliminary prespectus, we see ... 1.  346 - Naproxen identified for OA, RA, Ankylosing Spondylitis, dysmenorrhea, dental pain and general pain. more

RE:RE:Should You Sell Biotech Stocks If There's a Recession?

No one is buying the pump. Lost money on just abut every dollar you threw in here lol  rate and reply

RE:Q4 last year was end of june

Another useless post from the dumpster. We know it's going to be June 29th for 2022.  again this guy brings nothing to the table except videos and trolling comments. He's only here more

Q4 last year was end of june

Antibe Therapeutics Earnings Date & Reports FollowPortfolio   Earnings Data more

RE:Should You Sell Biotech Stocks If There's a Recession?

Thanks for sharing Davgro. Risk tolerance is the key here - it certainly won't be for everyone ... but ... there are a few really good points to consider. For risk-tolerant investors, more

RE:RE:If 2021 is any indication ...

Perfect - thanks Davgro ! --------------------------------------------------------  rate and reply

RE:If 2021 is any indication ...

The following is an excerpt from today's Thomson Reuters StockReports+ for ATE.  They have listed the next expected report date as June 29th, 2022.  rate and reply

Should You Sell Biotech Stocks If There's a Recession?

Interesting read from yesterday on the Motley Fool site.  rate and reply

RE:RE:ATE is in blackout

I finally decided to put all the trolls on Ignore.  I was engaging with the Dumpster for awhile but that became tiresome and I have quickly learned [again] that you can't fix stupid. more

If 2021 is any indication ...

Going into the last week of June ! It was on the last Monday of June 2021 that we received the financials and an update. It never seems to work out the same ... but ... conditions are similar in more

RE:RE:RE:ATE is in blackout

Thanks Magic.  Such a pathetic amount of dribble that these accounts put out. Appreciate you putting the list together so I can put them on ignore.  Adding absolutely no value whatsoever.  rate and reply
@ the Bell: Energy & mining recover to lift TSX
Following a nasty session in the red, Canada’s main stock index rose more than 300 points in Friday trading. Gains were led by the energy and base metal sectors.After two brutal weeks brought... read article.

we got a minnow on the line

  rate and reply

is today the day

 is ATE cheap enough yet to maybe catch a big fish today and pop up to 70 cents. unfortunatley all the longs are little minows and can not even avg down.  LOL  rate and reply
The Cannabis Report: June 24, 2022
Nextleaf to launch THC-O as an excise tax-free alternative to Delta-9-THC Nextleaf Solutions (OILS) has provided an update on the manufacturing of D9-tetrahydrocannabinol acetate,... read article.

RE:Wallace on Pride ...

Mugsy knows......! Fc....all  rate and reply

Xpeng is up 60% for me in a matter of months

while you guys throw nickels and dimes into the abyss  rate and reply

Wallace on Pride ...

"Night of the fight - you might feel a slight sting. That's pride ... F-ing wich you. F pride! Pride only hurts. It never helps." "You fight through that Sh#%. ... Cuz a year ( more

Mugsy is a clown

Mugsy may also be known as ProfessorCorneliuss  rate and reply
The Power Play by The Market Herald
< Previous Video {{moreVideoText}} Next Video >